Advanced Asset Management Advisors Inc Abb Vie Inc. Transaction History

Advanced Asset Management Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $9,405 - $11,279	68 New	68 $10,000
Q2 2018 Aug 02, 2018	SELL	$89.78 - $106.23 $1.69 Million - $2 Million	-18,855 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $1.69 Million - $1.85 Million	18,855	18,855 $1.82 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Advanced Asset Management Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Advanced Asset Management Advisors Inc with notifications on news.